SINGAPORE (Reuters) – Singapore has suspended the use of two flu vaccines as a precautionary measure after some people who received them in South Korea died, becoming among the first countries to publicly announce the cessation of vaccine use.
South Korea said 48 people died Saturday after receiving flu vaccines, but said it would continue with the state’s vaccination program because they found no direct link between the deaths and the shootings.
No deaths related to influenza vaccination have been reported in Singapore to date, but the decision to stop using SKYCellflu Quadrivalent and VaxigripTetra was a precaution, the health ministry and the health ministry (HAS) said in a statement late Sunday.
The HSA is in contact with the South Korean authorities for further information as they are investigating to determine whether the deaths were related to flu vaccinations.
SKYCellflu Quadrivalent is manufactured by South Korean SK Bioscience and is distributed locally by AJ Biologics, while VaxigripTetra is manufactured by Sanofi and locally distributed by Sanofi Aventis.
Two other flu vaccines imported into Singapore for the Northern Hemisphere 2020/21
Report by Aradhana Aravindan in Singapore; Edited by Miyoung Kim and Richard Chang